Rani Therapeutics Holdings Inc
Ownership
Ownership Structure
Who owns Rani Therapeutics Holdings Inc (RANI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 72.4% of the shares are freely tradable; institutional investors hold 43.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Samsara BioCapital, LLC | 8.98 | 10,369,159 | +22.0 | 06/30/2026 |
| RA Capital Management, LLC | 7.36 | 8,500,000 | +0.0 | 03/31/2026 |
| Awm Investment Company Inc | 5.63 | 6,500,000 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.00 | 4,622,567 | +0.0 | 03/31/2026 |
| SymBiosis Capital Partners, LLC | 3.18 | 3,667,585 | -41.8 | 03/31/2026 |
| Longaeva Partners L.P. | 2.02 | 2,329,459 | +10.2 | 03/31/2026 |
| Siren, L.L.C. | 1.73 | 2,000,000 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 0.78 | 903,298 | +4.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 3.16 | 3,646,699 | +0.0 | 07/31/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.72 | 834,894 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Imran Mir A | Director | 2,119,334 | 1,826,866 $ | Jul 21, 2026 | direct |
| Imran Talat | Chief Executive Officer | 469,736 | 404,912 $ | Jul 17, 2026 | direct |
| Javadi Alireza | Chief Technical Officer | 9,380 | 8,086 $ | Jun 27, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 21, 2026 | Imran Mir A | Director | Buy | 36,000 | 0.69 | 24,840 |
| Jul 17, 2026 | Imran Talat | Chief Executive Officer | Buy | 35,000 | 0.7198 | 25,193 |
| Jun 27, 2026 | Javadi Alireza | Chief Technical Officer | Other | 309 | 0.74 | 229 |
| Jun 27, 2026 | Imran Talat | Chief Executive Officer | Other | 7,927 | 0.74 | 5,866 |
| Mar 27, 2026 | Javadi Alireza | Chief Technical Officer | Sell | 386 | 0.78 | 301 |
| Mar 27, 2026 | Imran Talat | Chief Executive Officer | Other | 9,099 | 0.81 | 7,370 |
| Mar 22, 2026 | Imran Talat | Chief Executive Officer | Other | 8,916 | 1.13 | 10,075 |
| Dec 27, 2025 | Imran Talat | Chief Executive Officer | Other | 7,906 | 1.40 | 11,068 |
| Sep 27, 2025 | Imran Talat | Chief Executive Officer | Other | 9,077 | 0.48 | 4,357 |
| Jun 27, 2025 | Imran Talat | Chief Executive Officer | Other | 9,076 | 0.55 | 4,992 |
| Dec 27, 2024 | Imran Talat | Chief Executive Officer | Sell | 8,014 | 1.41 | 11,300 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.